98139376 - ZIXXIVUS

Information

• Trademark
• 98139376

• Source

• Serial Number

  98139376

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  August 18, 2023
  9 months ago

• Transaction Date

  February 13, 2024
  3 months ago

• Status Date

  February 13, 2024
  3 months ago

• Published for Opposition Date

  December 19, 2023
  5 months ago

• Location Date

  February 13, 2024
  3 months ago

• Status Code

  688

• Current Location

  INTENT TO USE SECTION

  Employee Name

  WOOD, CAROLINE

• Attorney Docket Number

  VAND-0093US4

  Attorney Name

  Jayme M. Torelli

  Law Office Assigned Location Code

  M10

• Owners

  • Vanda Pharmaceuticals, Inc.

Case File Statements

• GS0051: Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the prevention of motion sickness; Pharmaceutical preparations for the prevention of social anxiety or performance anxiety; Pharmaceutical preparations for the treatment and prevention of craving; Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of insomnia; Pharmaceutical preparations for the treatment and prevention of social anxiety or performance anxiety; Pharmaceutical preparations for the treatment of circadian rhythm diseases and disorders; Pharmaceutical preparations for the treatment of Non-24-Hour Sleep-Wake Disorder; Pharmaceutical preparations for the treatment of jet lag disorder; Pharmaceutical preparations for the treatment of Delayed Sleep Phase Disorder (DSPD); Pharmaceutical preparations for the treatment of bipolar disorder; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of motion sickness; Pharmaceutical preparations for the treatment of hematologic malignancies; Pharmaceutical preparations for the treatment of insomnia; Pharmaceutical preparations for the treatment of Autism Spectrum Disorder (ASD); Pharmaceutical preparations for the treatment of Parkinson's Disease Psychosis; Pharmaceutical preparations for the treatment of COVID-19 pneumonia; Pharmaceutical preparations for the treatment of social anxiety or performance anxiety; Pharmaceutical preparations for the treatment of Smith-Magenis Syndrome; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology

Case File Event Statements

• 2/13/2024 - 3 months ago

  8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 12/19/2023 - 5 months ago

  7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 12/19/2023 - 5 months ago

  6 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/29/2023 - 5 months ago

  5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 11/16/2023 - 6 months ago

  4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/13/2023 - 6 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 9/18/2023 - 8 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/22/2023 - 9 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP